Non-Biological Complex Drugs The Science and the Regulatory Landscape /
The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufactu...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2015.
|
Σειρά: | AAPS Advances in the Pharmaceutical Sciences Series,
20 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Introduction: Defining the position of Non-Biological Complex Drugs
- Polymeric micelles
- Liposomes: the science and the regulatory landscape
- Glatiramoids
- Iron carbohydrate complexes: characteristics and regulatory challenges
- Drug Nanocrystals
- Analytical methods for determining the size (distribution) in parenternal dispersions
- NBCD Pharmacokinetics and Bioanalytical Methods to Measure Drug Release
- Low Molecular Weight Heparins, Biological Drugs close to Non-Biological Complex Drugs
- Nanoparticle Albumin-Bound Anticancer Agents
- The EU regulatory landscape of Non-Biological Complex Drugs
- What did we learn? What can we expect in the future? Concluding remarks and outstanding issues.